Jacobson Pharma Group Competitors and Similar CompaniesClear all

Jacobson Pharma Group's competitors and similar companies include Clinigen, Gilead Sciences, Chiesi Australia and Purna Pharmaceuticals.

	Jacobson Pharma Group Jacobson Pharma Group is a manufacturer of pharmaceutical products.	Clinigen Clinigen is a specialist pharmaceutical services company.	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.	Chiesi Australia Chiesi Australia is a pharmaceutical company that specializes in drug development.	Purna Pharmaceuticals Purna Pharmaceuticals is a developer, and manufacturer of pharmaceutical products.
Founding Date	Founding Date 1996	Founding Date 2010	Founding Date 1987	Founding Date 1935	Founding Date 1986
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Private
Tags	Tags Manufacturing & Industrial clinical research drug development pharma	Tags Manufacturing & Industrial clinical research drug development pharma	Tags Manufacturing & Industrial biotech clinical research drug development pharma	Tags Healthcare drug development pharma	Tags Manufacturing & Industrial clinical research drug development pharma
Locations	Locations HK HQ	Locations Burton upon Trent, GB HQ Warriewood, AU Lyon, FR Koropi, GR Lismore, IE Chuo City, JP Singapore, SG see more	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more	Locations Melbourne, AU HQ	Locations Puurs, BE HQ
Employees	Employees 65	Employees 586	Employees 18,0006% increase	Employees 433% increase	Employees 1442% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £562.2m (FY, 2021)	Revenue (est.) $29.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods £301.2m (FY, 2021)	Cost of goods $6.2b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit £261m (FY, 2021)	Gross profit $23.2b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income £38.7m (FY, 2021)	Net income $8.5b (FY, 2025)	Net income N/A	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 43 (FY, 2016)	Countries 35 (FY, 2021)	Countries N/A	Countries N/A